Analyst Research Report Snapshot

Title:

PROMETIC LIFE SCIENCES - REVENUE RECEIPTS ROLL IN

Price:

$10.00

Provider:

Edison Investment Research

Date:

03 Feb 2012

Pages:

2

Type:

AcrobatPDF

Companies referenced:

PLI.TO

Available for Immediate Download
Summary:

Confirmation of near-term purchase orders and service revenues from key customers means that ProMetic Life Sciences has improved visibility on near-term revenue predictability. The company is now emerging from a period where there was a gap in major orders, and expects 2012 to be a stronger year for revenues. This view is supported by the trigger of a $1m upfront payment related to the $2.5m H112 purchase order under its Octapharma supply agreement, and also the achievement of a key milestone with an undisclosed multinational company, leading to confirmed service revenues in 2012 and a potential long-term resin supply agreement.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.